rimegepant

Biohaven migraine drug partnered with Pfizer lands twin European approvals
MedCity News
Wed, 04/27/22 - 10:38 pm
Europe
Pfizer
Biohaven
migraines
rimegepant
Pfizer and Biohaven close collaboration agreements
Pharmaceutical Business Review
Thu, 01/6/22 - 10:54 am
Pfizer
Biohaven
rimegepant
zavegepant
Nurtec ODT
migraines
Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs
Yahoo/Reuters
Tue, 11/9/21 - 10:38 am
Pfizer
Biohaven
migraines
rimegepant
zavegepant
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
ICER
migraines
Biohaven
Allergan
ubrogepant
rimegepant
Eli Lilly
Lasmiditan
New Meds Set to Reshape US CNS and oncology Markets
Xconomy
Tue, 02/18/20 - 08:36 pm
CNS
oncology
cancer
Clarivate Analytics
Biohaven
rimegepant
Novartis
OMB-157
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
Fri, 01/3/20 - 11:03 pm
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
Biohaven, sporting new data, moves closer to CGRP finish line—and maybe M&A
Fierce Pharma
Fri, 07/12/19 - 09:50 am
Biohaven
migraines
CGRP blockers
rimegepant
Biohaven is betting hundreds of millions it can hustle ahead of rivals in a blockbuster race. A quick M&A deal could pay off backers big time
Endpoints
Mon, 03/18/19 - 12:13 pm
Biohaven
migraines
rimegepant
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink
Xconomy
Mon, 03/26/18 - 09:54 am
Allergan
Biohaven Pharmaceuticals
migraines
rimegepant